Perpetual Ltd’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
MCI
GA
BS
Perpetual Ltd's REGN Position: Q2 2026 in Review
Perpetual Ltd increased its Regeneron Pharmaceuticals (REGN) stake by 12% in Q2 2026, buying an estimated $178K and bringing the position to 2,407 shares worth $1.5M. The position accounts for 0.02% of the portfolio, ranked #193.
Perpetual Ltd first reported a position in REGN in Q3 2016 and has held it in 17 quarters since. The position peaked at $100M in Q1 2023. 419 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- Perpetual Ltd held 2,407 shares of Regeneron Pharmaceuticals worth $1.5M as of Q2 2026.
- Perpetual Ltd bought 262 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $178K.
- Regeneron Pharmaceuticals made up 0.02% of Perpetual Ltd's portfolio in Q2 2026, its #193 holding.
- Perpetual Ltd first reported a position in Regeneron Pharmaceuticals in Q3 2016 and has held it in 17 quarters since.
- Perpetual Ltd's Regeneron Pharmaceuticals position peaked at $100M in Q1 2023.
- 419 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on Perpetual Ltd's 13F filing for Q2 2026, filed 15 Jul 2026.